Acute Generalized Exanthematous Pustulosis
"Acute Generalized Exanthematous Pustulosis" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Rare skin eruption characterized by acute formation of pustules filled with NEUTROPHILS, fever, and peripheral blood LEUKOCYTOSIS. Most cases are associated with the use of antibiotics (e.g., BETA-LACTAMS).
| Descriptor ID |
D056150
|
| MeSH Number(s) |
C17.800.174.600.174 C20.543.206.380.174 C25.100.468.380.174
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Acute Generalized Exanthematous Pustulosis".
Below are MeSH descriptors whose meaning is more specific than "Acute Generalized Exanthematous Pustulosis".
This graph shows the total number of publications written about "Acute Generalized Exanthematous Pustulosis" by people in this website by year, and whether "Acute Generalized Exanthematous Pustulosis" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2015 | 1 | 0 | 1 |
| 2017 | 1 | 1 | 2 |
| 2018 | 2 | 0 | 2 |
| 2019 | 1 | 0 | 1 |
| 2020 | 4 | 0 | 4 |
| 2021 | 2 | 0 | 2 |
To return to the timeline, click here.
Below are the most recent publications written about "Acute Generalized Exanthematous Pustulosis" by people in Profiles.
-
Acute generalized exanthematous pustulosis following treatment with favipiravir in a patient with COVID-19 without hydroxychloroquine use: Report of the first case. J Cosmet Dermatol. 2021 Aug; 20(8):2387-2389.
-
COVID-19 vaccine-induced acute generalized exanthematous pustulosis. Korean J Intern Med. 2021 11; 36(6):1537-1538.
-
COVID-19 presenting as acute generalized exanthematous pustulosis associated with multiorgan dysfunction in a 44-year-old female patient. Rev Inst Med Trop Sao Paulo. 2021; 63:e42.
-
Acute Generalized Exanthematous Pustulosis (AGEP) in 12 Patients Treated for SARS-CoV-2 Positive Pneumonia. Am J Dermatopathol. 2021 May 01; 43(5):342-348.
-
Severe adverse drug reaction in SARS-CoV-2 infection: AGEP induced by ceftriaxone and confirmed by patch test. Contact Dermatitis. 2021 09; 85(3):366-368.
-
Acute generalized exanthematous pustulosis and Stevens-Johnson syndrome overlap due to hydroxychloroquine: a case report. J Med Case Rep. 2020 Nov 03; 14(1):210.
-
Delayed Presentation of Acute Generalized Exanthematous Pustulosis Following Treatment with Cefepime in a Patient with COVID-19 without the Use of Hydroxychloroquine. Am J Case Rep. 2020 Oct 24; 21:e926901.
-
Acute generalized exanthematous pustulosis with a focus on hydroxychloroquine: A 10-year experience in a skin hospital. Int Immunopharmacol. 2020 Dec; 89(Pt B):107093.
-
Late-onset AGEP-like skin pustular eruption following COVID-19: A possible association. Dermatol Ther. 2020 11; 33(6):e14275.
-
Acute generalized exanthematous pustulosis induced by empiric hydroxychloroquine for presumed COVID-19. Dermatol Ther. 2020 Nov; 33(6):e13834.